Journal article

Why are drug trials in Alzheimer's disease failing?

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Smith, A. (2010). Why are drug trials in Alzheimer's disease failing? Lancet, 376(9751), 1466.

MLA Style

Smith, A. “Why Are Drug Trials in Alzheimer's Disease Failing?” Lancet, vol. 376, no. 9751, 2010, p. 1466.

Chicago Style

Smith, A. 2010. “Why Are Drug Trials in Alzheimer's Disease Failing?” Lancet 376 (9751): 1466.
Print

Access Document

Publisher copy:: 10.1016/s0140-6736(10)61994-0

Authors

+ Smith, A More by this author

Role:: Author

Journal:: Lancet More from this journal
Volume:: 376
Issue:: 9751
Pages:: 1466
Publication date:: 2010-10-01
DOI:: 10.1016/s0140-6736(10)61994-0
EISSN:: 1474-547X
ISSN:: 0140-6736

Language:: English
Keywords:: Humans

Treatment Failure

Alzheimer Disease

Amyloid beta-Peptides

Clinical Trials as Topic
Pubs id:: pubs:195509
UUID:: uuid:f7156ffa-6579-4bbf-a8c4-8f240c634b73
Local pid:: pubs:195509
Source identifiers:: 195509
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_f7156ffa65794bbfa8c48f240c634b73

Terms of use

Copyright date:: 2010

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP